Latest / Health and life sciences

DealHealthSouth Korea New Zealand USConfirmed

Lunit agrees to buy Volpara Health for about US$193m

See how this story connects

South Korean medical AI company Lunit signed a scheme implementation agreement on 14 December 2023 to buy Volpara Health Technologies of Wellington, New Zealand, for AUD 1.15 a share in cash, about AUD 292 million (US$193 million). The price was a 47.4% premium to Volpara’s previous close. Volpara’s AI mammography software runs at more than 2,000 US sites, and closing was expected by the end of the second quarter of 2024 subject to shareholder, court and investment approvals.

Why it matters

A Korean cancer-screening AI company bought an installed US customer base in breast imaging, and buyers of mammography AI faced a larger combined supplier.

When
14 Dec 2023
ID
WTA-N-2023-0153
Where
South Korea, New Zealand, United States
Who
Lunit, Volpara Health Technologies

Summary by wheresthe.ai, from Lunit and the reporting credited above. Checked against the source on 9 Oct 2026.

Source copy: download the page as saved on 18 Oct 2026 (PDF). Also held by the Internet Archive.

Earlier in this Storyline: What led hereSwedish MASAI trial finds AI-supported mammography reading cuts workload by 44%

Cite this story

WTA-N-2023-0153: “Lunit agrees to buy Volpara Health for about US$193m.” wheresthe.ai, 14 Dec 2023. https://wheresthe.ai/d/kr-lunit-volpara-acquisition-2023-12/ (source: Lunit).

Spotted an error? Email [email protected].